Document is current
Any future updates will be listed below
-
Authors
Timm, Morgan R. http://orcid.org/0000-0002-2947-9508
Russell, Seongmi K. http://orcid.org/0000-0003-2012-4492
Hultgren, Scott J. http://orcid.org/0000-0001-8785-564X
- License Information
-
More Information
Article History
Accepted: 25 July 2024
First Online: 9 September 2024
Competing interests
: S.J.H. has an ownership interest in Fimbrion Therapeutics and may benefit if the company is successful in marketing mannosides. S.J.H. is also the chief scientific officer of QureTech Bio. S.J.H. is an inventor on multiple patents pertaining to urinary tract infection therapeutics including the FimCH and EbpA vaccines. M.R.T. and S.J.H are inventors on a patent for the Abp2D vaccine. S.K.R. declares no competing interests.
